The Pentagon has issued a directive requiring all active-duty and reserve service members aged 30 and above to undergo mandatory screening for testosterone deficiency. This move is part of a broader effort by the Trump administration to enhance military readiness and combat performance. Chief Pentagon Spokesman Sean Parnell announced the new policy, emphasizing the goal to optimize combat effectiveness and address “Operator Syndrome.”
The screening protocol, effective immediately, will be integrated into the Periodic Health Assessment for personnel aged 30 and older. Service members under 30 can also request this screening during their health assessment. The Pentagon aims to create a strong and prepared fighting force capable of dominating the battlefield and promoting peace through strength.
This initiative aligns with the Department’s “Warfighter Performance Optimization – Total Force Fitness” program, focusing on enhancing the health, performance, and resilience of the military. By establishing a comprehensive baseline and offering targeted testosterone therapy, the Department aims to maintain a healthy and capable fighting force. The policy emphasizes the importance of treating Operator Syndrome and optimizing warfighter readiness.
The directive mandates the inclusion of testosterone deficiency screening in the health assessment process for personnel over 30. It also encourages service members below 30 to voluntarily undergo the screening. The Department aims to leverage lessons learned from treating Operator Syndrome to enhance warfighter readiness and combat effectiveness. The Pentagon is set to update policies and educate medical personnel and service members on the implementation of this new screening requirement.
